Latest Articles for Pharmaceuticals

Study suggests SSRIs may lower Long COVID risk in patients with depression.

The Solidarity Finland trial evaluates imatinib's effectiveness in COVID-19 treatment.

PAPEORS shows promise for better chiral molecule detection in medical settings.

AI is changing the way new drugs are developed, making it faster and more efficient.

New strategies enhance accuracy in predicting drug compound effectiveness.

Exploring the benefits of prednisolone and mepolizumab for asthma management.

This study examines how contextual knowledge enhances the detection of adverse drug events.

A new method enhances accuracy in predicting protein-ligand interactions.

Exploring how soft materials change behavior under stress and its implications.

Exploring how cDFT enhances our understanding of fluid interactions and solvation.

Examining beta-blockers and salbutamol's effects on prostate cancer risk and survival.

Study examines opioid prescriptions in England amid COVID-19 challenges.

Learn the basics and future potential of quantum computing technology.

Recent studies highlight potential benefits of early Aβ-targeting treatments for Alzheimer’s.

Nivolumab shows promise in treatment, but cost-effectiveness raises concerns.

A new approach to dose-finding trials enhances efficiency and accuracy in drug development.

A new approach improves peptide drug design using AI and a comprehensive dataset.

Examining modafinil's role in enhancing student performance and its ethical implications.

Reviewing effective antiviral options for treating COVID-19 and ongoing trials.

A new policy in Israel reduces dangerous fentanyl prescriptions, especially among younger patients.

New databases improve tracking of harmful medication effects.

Review of antipsychotic prescription trends for severe mental illnesses in the UK.

Investigating how hairy particles change shape at liquid-liquid boundaries.

Research aims to improve oral peptide drugs for diabetes management.

Two new treatments for Alzheimer's show promise but raise safety concerns.

A new model, MolCRAFT, improves drug design by generating realistic molecular structures.

Analyzing the impact and risks of common cholesterol-lowering medications.

A comprehensive study on treatments for age-related eye diseases in older adults in China.

A tool for accurate simulation of two-phase liquid interactions.

Examining how gut microbiome impacts the absorption of antipsychotic medications.

Research reveals limited links between genetics and current mental health therapies.

Study examines aspirin's impact on blood clot risks in Veterans after COVID-19.

Strategies for optimizing systems by minimizing regret in uncertain environments.

Examining financial relationships and their impact on healthcare practices.

Study confirms diluted treprostinil remains stable for 76 hours in pump cassettes.

DrugCLIP uses AI to speed up virtual screening for new drug candidates.

New techniques in AI enhance protein structure prediction and design.

High-Resolution Atomic Force Microscopy aids in precise molecular identification.

Research shows antidepressants may alter DNA methylation related to mental health.

This article examines the effects of temperature and viscosity on polymer behavior.